# Clinical Trial of Factor XIII (FXIII) Concentrate

> **NCT00640289** · NA · COMPLETED · sponsor: **Children's Hospital of Orange County** · enrollment: 72 (actual)

## Conditions studied

- Hemophilia
- Factor XIII Deficiency

## Interventions

- **DRUG:** Fibrogammin P

## Key facts

- **NCT ID:** NCT00640289
- **Lead sponsor:** Children's Hospital of Orange County
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-01
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2018-11-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00640289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00640289, "Clinical Trial of Factor XIII (FXIII) Concentrate". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00640289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*